Immediate Impact
1 by Nobel laureates 2 from Science/Nature 60 standout
Citing Papers
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
2022 Standout
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
2022 Standout
Works of Andrew Parton being referenced
Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Andrew Parton | 834 | 11 | 102 | 169 | 135 | 38 | 1.4k | |
| J D Degos | 344 | 20 | 89 | 102 | 47 | 40 | 1.1k | |
| Andreas Stevens | 306 | 51 | 230 | 128 | 111 | 63 | 1.3k | |
| M. Haupts | 416 | 38 | 55 | 152 | 116 | 43 | 1.1k | |
| Miao Chang | 709 | 41 | 31 | 158 | 183 | 54 | 1.4k | |
| Andrea Crowell | 568 | 18 | 59 | 88 | 92 | 43 | 1.7k | |
| Crystal Franklin | 518 | 32 | 72 | 72 | 86 | 38 | 1.2k | |
| Meichen Yu | 1006 | 60 | 86 | 57 | 257 | 31 | 1.6k | |
| Stephanie Ohlraun | 256 | 34 | 88 | 57 | 349 | 37 | 1.7k | |
| Morton D. Low | 475 | 46 | 156 | 41 | 97 | 28 | 1.5k | |
| Jin‐Yan Wang | 323 | 26 | 34 | 131 | 144 | 77 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...